Compare Fresenius Medical Care AG with Similar Stocks
Dashboard
1
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 1.58% and Operating profit at -7.20% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- OPERATING PROFIT TO INTEREST (Q) Lowest at 7.01 times
- CASH AND CASH EQUIVALENTS(HY) Lowest at EUR 1,148.00 MM
- DEBTORS TURNOVER RATIO(HY) Lowest at 4.87 times
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.33%
0%
-5.33%
6 Months
-11.75%
0%
-11.75%
1 Year
-15.39%
0%
-15.39%
2 Years
8.26%
0%
8.26%
3 Years
0.13%
0%
0.13%
4 Years
-35.89%
0%
-35.89%
5 Years
-39.23%
0%
-39.23%
Fresenius Medical Care AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.91%
EBIT Growth (5y)
-2.96%
EBIT to Interest (avg)
4.39
Debt to EBITDA (avg)
2.10
Net Debt to Equity (avg)
0.44
Sales to Capital Employed (avg)
0.82
Tax Ratio
33.92%
Dividend Payout Ratio
44.35%
Pledged Shares
0
Institutional Holding
0.09%
ROCE (avg)
8.54%
ROE (avg)
8.48%
Valuation key factors
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.88
EV to EBIT
9.51
EV to EBITDA
5.32
EV to Capital Employed
0.92
EV to Sales
0.91
PEG Ratio
0.21
Dividend Yield
3.62%
ROCE (Latest)
9.63%
ROE (Latest)
9.89%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 3 Foreign Institutions (0.09%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
5,070.00
4,884.90
3.79%
Operating Profit (PBDIT) excl Other Income
951.00
856.30
11.06%
Interest
99.00
93.10
6.34%
Exceptional Items
-44.00
-11.60
-279.31%
Consolidate Net Profit
403.00
327.30
23.13%
Operating Profit Margin (Excl OI)
114.00%
102.00%
1.20%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 3.79% vs 1.95% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 23.13% vs 20.20% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
19,636.90
19,337.70
1.55%
Operating Profit (PBDIT) excl Other Income
3,347.90
3,179.60
5.29%
Interest
354.30
397.10
-10.78%
Exceptional Items
-34.40
-487.20
92.94%
Consolidate Net Profit
1,191.30
740.90
60.79%
Operating Profit Margin (Excl OI)
96.00%
85.00%
1.10%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 1.55% vs -0.60% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 60.79% vs 1.15% in Dec 2024
About Fresenius Medical Care AG 
Fresenius Medical Care AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






